FindTrial
Sign In

Efficacy of the combined therapy of sitagliptin and insulin in japanese type 2 diabetic patients

Efficacy of the combined therapy of sitagliptin and insulin in japanese type 2 diabetic patients - sitagliptin and insulin

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000007075
Enrollment
50
Registered
2012-01-16
Start date
2011-11-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

type 2 diabetes

Interventions

sitagliptin

Sponsors

Fukuoka university, school of medicine, department of endocrinology and diabetes mellitus
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: type 2 diabetic patients in basal-bolus insulin therapy

Exclusion criteria

Exclusion criteria: type 1 diabetic patients insulin dependent diabetes mellitus renal failure history of ketosis

Design outcomes

Primary

MeasureTime frame
blood glucose HbA1c Continuous Glucose Monitering—

Secondary

MeasureTime frame
hypoglycemic attack—

Countries

Japan

Contacts

Public ContactTakashi Nomiyama

Fukuoka university, school of medicine Department of endicrinology and diabetes mellitus

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026